GAIN THERAPEUTICS, INC (GANX) Total liabilities 2021–2024
GAIN THERAPEUTICS, INC (GANX) total liabilities at each fiscal year-end, per SEC filings.
$6.0MFY2024 · since FY2021: $3.4M → $6.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $6.0M | +15.5% |
| FY2023 | $5.2M | +25.3% |
| FY2022 | $4.2M | +22.5% |
| FY2021 | $3.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice